Top Page
Latrobe Magnesium Limited
(Sydney:LMG)
Latrobe Magnesium Limited (LMG) vs. S&P 500 (SPY)
Latrobe Magnesium Limited Business Overview & Revenue Model
Latrobe Magnesium Limited Financial Statement Overview
| Breakdown | ||||
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Gross Profit |
| -41.68K | -55.28K | -199.05K | -135.94K | -57.61K | EBIT |
| -5.71M | -4.37M | -4.52M | -2.29M | -1.97M | EBITDA |
| -5.36M | -4.26M | -4.30M | -1.31M | -1.89M | Net Income Common Stockholders |
| -4.74M | -2.44M | -3.21M | 120.26K | -2.08M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 565.15K | 6.89M | 15.25M | 954.25K | 38.53K | Total Assets |
| 95.40M | 62.47M | 37.39M | 12.31M | 15.89M | Total Debt |
| 13.86M | 15.37M | 5.59M | 698.40K | 3.39M | Net Debt |
| 13.30M | 8.48M | -9.66M | -255.85K | 3.36M | Total Liabilities |
| 53.78M | 36.16M | 14.68M | 8.15M | 12.24M | Stockholders Equity |
| 41.63M | 26.31M | 22.71M | 4.16M | 3.66M |
| Cash Flow | Free Cash Flow | |||
| -15.85M | -22.31M | -9.42M | 4.53M | -1.06M | Operating Cash Flow |
| 11.50M | -4.31M | -3.74M | 5.89M | -1.06M | Investing Cash Flow |
| -16.98M | -18.04M | -5.69M | -1.54M | -8.22K | Financing Cash Flow |
| -854.18K | 13.99M | 23.72M | -3.43M | 701.73K |
Latrobe Magnesium Limited Technical Analysis
Latrobe Magnesium Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
57 Neutral | $33.73M | 6.36 | 15.74% | ― | ― | ― | |
54 Neutral | AU$39.89M | ― | -34.02% | ― | -48.45% | 49.82% | |
49 Neutral | $1.94B | -1.23 | -21.28% | 3.73% | 1.19% | -29.73% | |
46 Neutral | AU$85.22M | ― | -15.37% | ― | ― | -34.41% | |
46 Neutral | €119.86M | ― | ― | ― | ― | ||
38 Underperform | AU$16.52M | ― | -26.98% | ― | ― | -200.00% | |
32 Underperform | AU$30.58M | ― | -0.86% | ― | ― | 97.62% |
Latrobe Magnesium Limited Corporate Events
Latrobe Magnesium Limited announced significant progress in its operations, including the planned commencement of its demonstration plant by late May 2025, supported by $6.3 million in funding. The company is also advancing the sale of surplus land to generate up to $5 million, which will aid in further development and operational needs. Additionally, LMG secured a 250MW allocation of hydropower for its Stage 3 Project in Sarawak, Malaysia, and received project development support from the Australian Government. The company is pursuing a $19.39 million counterclaim against Mincore for breach of contract and negligence, with mediation expected by June 2025.
Latrobe Magnesium Limited has successfully raised $2.2 million through a private placement by issuing 200 million fully paid ordinary shares at $0.011 each to sophisticated and professional investors. This strategic move enhances the company’s financial position and aligns with its growth objectives, potentially impacting its market presence and offering new opportunities for stakeholders.
Latrobe Magnesium Limited has announced the issuance of 20 million unquoted securities, set to expire in April 2028, as part of previously disclosed transactions. This move indicates the company’s ongoing efforts to strengthen its financial position and operational capabilities, potentially impacting its market strategy and stakeholder interests.
Latrobe Magnesium Limited has announced the issuance of 200 million fully paid ordinary securities, which will be quoted on the Australian Securities Exchange (ASX) under the code LMG. This move is part of a previously announced transaction, and it is expected to bolster the company’s financial position, potentially enhancing its capacity to advance its magnesium production initiatives and strengthen its market presence.
Latrobe Magnesium Limited (LMG) has confirmed that its magnesium exports to the United States will not be subject to new tariffs imposed by the US on global imports. This exemption highlights magnesium’s critical status in the US and strengthens LMG’s market position, especially as tariffs on Chinese magnesium increase, making LMG more competitive. The company’s plans to sell its magnesium production to the US market align with recent demand from the US Defense Department, further solidifying its strategic importance.
Latrobe Magnesium Limited has corrected a previous announcement and confirmed the placement of 250 million shares at 1.1 cents per share. As part of the capital raising, LMG is issuing 20 million unlisted options to the lead manager or broker of the placement, with each option convertible into one ordinary share at an exercise price of 1.9 cents. These options are exercisable until April 2028, and the shares issued upon exercise will rank equally with existing shares. This move is part of LMG’s financial strategy to bolster its capital structure and enhance its market operations.
Latrobe Magnesium Limited has announced a proposed issue of securities, comprising 250,000,000 ordinary fully paid shares and 20,000,000 options expiring in April 2028. This move is part of the company’s strategic efforts to raise capital, potentially enhancing its financial position and supporting its operational goals in the magnesium production sector.
Latrobe Magnesium Limited has successfully placed 250 million shares at 1.9 cents each and is issuing 20 million unlisted options as part of the capital raising costs. These options, which are not quoted on the ASX, can be converted into ordinary shares at an exercise price of 1.9 cents until April 2028, potentially impacting the company’s capital structure and shareholder value.
Latrobe Magnesium Limited has announced an equity capital raising initiative, involving a placement of shares to sophisticated and professional investors, as well as a share purchase plan. This move is intended to support the company’s financial growth and operational expansion, potentially enhancing its market position and offering new opportunities for stakeholders.
Latrobe Magnesium Limited announced a proposed issue of 68,181,818 ordinary fully paid securities under a securities purchase plan. This move is aimed at raising capital, potentially enhancing the company’s operational capabilities and market position, and offering stakeholders an opportunity to invest further in the company.
Latrobe Magnesium Limited has secured $6.3 million in funding to restart its Demonstration Plant by late May, aiming to produce magnesium oxide and achieve steady state operations. The funding, which includes institutional placements and a share purchase plan, will support the company’s strategy to derisk its technology and processes amidst challenging market conditions. The company plans to sell the produced MgO to Australian customers, and the funding will also aid in permitting activities for future projects, enhancing its industry positioning and stakeholder confidence.
Latrobe Magnesium Limited has requested a trading halt on its securities pending a significant announcement regarding a proposed capital raising. This move indicates a strategic financial maneuver that could impact the company’s operations and market positioning, potentially affecting stakeholders and investors.
Latrobe Magnesium Limited has secured a 250 MW hydropower allocation for its Sarawak project, marking a significant milestone as power demand in the region exceeds supply, enabling the company to advance discussions with potential joint venture partners. Additionally, LMG has received funding from the Australian Federal Government’s Southeast Asia Investment Deal Team’s Project Development Support Program, highlighting the competitiveness of the initiative and supporting the establishment of its Stage 3 Project in Sarawak, Malaysia.
Latrobe Magnesium Limited has released its half-year financial report for the period ending December 31, 2024. This report provides insights into the company’s financial performance, including statements of profit or loss, financial position, changes in equity, and cash flows. The release of this report is crucial for stakeholders to assess the company’s financial health and strategic positioning within the industry.